To determine whether the ability to recognize tumor antigens is responsible for the enhancement of antitumor immunity in this model system, we transferred ex vivo—expanded CD4+ T cells from OT-II transgenic mice into sublethally irradiated lymphopenic mice. This evidence concerns the gene CD4 and neoplasm.